Background It has been proposed that magnetic resonance imaging (MRI) be used to guide
breast cancer surgery by differentiating residual tumor from pathologic complete response …

Neoadjuvant (primary systemic) treatment has become a standard option for primary
operable disease for patients who are candidates for adjuvant systemic chemotherapy …

The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA
organised a workshop in Milan on 20–21st October 2008 to evaluate the evidence currently …

We discuss a bent-ray ultrasound tomography algorithm with total-variation (TV)
regularization. We have applied this algorithm to 61 in vivo breast datasets collected with …

OBJECTIVE. The objective of our study was to determine the relative accuracy of
mammography, sonography, and MRI in predicting residual tumor after neoadjuvant …

Magnetic resonance (MR) imaging is emerging as the most sensitive modality that is
currently available for the detection of primary or recurrent breast cancer. Although this …

Objectives This systematic review aimed to assess the role of magnetic resonance imaging
(MRI) in evaluating residual disease extent and the ability to detect pathologic complete …

BACKGROUND: Increased pathologic complete response (pCR) rates observed with
neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer …

Purpose To determine the relationship of breast magnetic resonance imaging (MRI) to
outcome after breast-conservation treatment (BCT) with radiation for women with early-stage …

OBJECTIVE. This study was undertaken to evaluate the ability of MRI to accurately show
residual primary breast malignancy in women treated with neoadjuvant chemotherapy …